Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fujun Yang

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
JAMA Network Open|December 12, 2023
Opportunistic Screening With Low-Dose Computed Tomography and Lung Cancer Mortality in ChinaLijie Wang, Yue Qi, Ailing Liu, et al.
BMC Medical Research Methodology|January 23, 2024
Predicting lung cancer survival prognosis based on the conditional survival bayesian networkLu Zhong, Fan Yang, Shanshan Sun, et al.
BMC Medicine|December 19, 2024
Efficacy, safety, and biomarker analysis of first-line immune checkpoint inhibitors with chemotherapy versus chemotherapy for advanced gastric cancer: a multicenter, retrospective cohort studyXue Zhang, Xin Dai, Aina Liu, et al.
BMC Medicine|February 12, 2025
Correction: Efficacy, safety, and biomarker analysis of first-line immune checkpoint inhibitors with chemotherapy versus chemotherapy for advanced gastric cancer: a multicenter, retrospective cohort studyXue Zhang, Xin Dai, Aina Liu, et al.
Future Oncology (London, England)|October 30, 2025
Safety of osimertinib in Chinese patients with non-small cell lung cancer: a multi-center, prospective, observational studyHua Zhong, Shunjun Jiang, Wenxiu Yao, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
JAMA Network Open|December 12, 2023
Opportunistic Screening With Low-Dose Computed Tomography and Lung Cancer Mortality in ChinaLijie Wang, Yue Qi, Ailing Liu, et al.
BMC Medical Research Methodology|January 23, 2024
Predicting lung cancer survival prognosis based on the conditional survival bayesian networkLu Zhong, Fan Yang, Shanshan Sun, et al.
BMC Medicine|December 19, 2024
Efficacy, safety, and biomarker analysis of first-line immune checkpoint inhibitors with chemotherapy versus chemotherapy for advanced gastric cancer: a multicenter, retrospective cohort studyXue Zhang, Xin Dai, Aina Liu, et al.
BMC Medicine|February 12, 2025
Correction: Efficacy, safety, and biomarker analysis of first-line immune checkpoint inhibitors with chemotherapy versus chemotherapy for advanced gastric cancer: a multicenter, retrospective cohort studyXue Zhang, Xin Dai, Aina Liu, et al.
Future Oncology (London, England)|October 30, 2025
Safety of osimertinib in Chinese patients with non-small cell lung cancer: a multi-center, prospective, observational studyHua Zhong, Shunjun Jiang, Wenxiu Yao, et al.
Pageof 9